Posted by Michael Wonder on 01 Dec 2017
Continuing to make new medicines affordable for Australians
1 December 2017 - A new medicine to treat soft tissue sarcoma will be available through the Pharmaceutical Benefits Scheme, giving more than 100 Australians a year access to affordable life-improving treatment.
A new medicine to treat soft tissue sarcoma will be available through the Pharmaceutical Benefits Scheme from today, giving more than 100 Australians a year access to affordable life-improving treatment.
Eribulin (Halaven) provides eligible patients with an alternative treatment to currently listed medicines. It works by inhibiting the growth of cancer cells.
